T. I. Smolyanova

N-terminal and C-terminal fragments of IGFBP-4 as novel biomarkers for short-term risk assessment of major adverse cardiac events in patients presenting with ischemia

Alexander B. Postnikov, T. I. Smolyanova, Alexey V. Kharitonov et al. · Clinical Biochemistry · 2012 · 41 citations

Medicine, Cardiology, Pharmacology +14

Characterization of endogenously circulating IGFBP-4 fragments—Novel biomarkers for cardiac risk assessment

Alexey A. Konev, T. I. Smolyanova, Alexey V. Kharitonov et al. · Clinical Biochemistry · 2015 · 23 citations · Full text

Life Sciences, Biochemistry, Cardiology +16

Clinical differences between total PAPP-A and measurements specific for the products of free PAPP-A activity in patients with stable cardiovascular disease

Olaf Schulz, Alexander B. Postnikov, T. I. Smolyanova et al. · Clinical Biochemistry · 2013 · 13 citations

Medicine, Cardiology, Clinical Cardiology +5

Phase I Pharmacokinetics Study of Drug «COVID-globulin» (Specific Human Immunoglobulin Against COVID-19)

T. I. Smolyanova, N. S. Bagaevа, I. E. Shohin et al. · Drug development & registration · 2022 · 13 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Infectious Diseases +14